118 related articles for article (PubMed ID: 8606869)
1. Immunoreactive p53 protein in high-grade prostatic intraepithelial neoplasia.
Humphrey PA; Swanson PE
Pathol Res Pract; 1995 Sep; 191(9):881-7. PubMed ID: 8606869
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
Tamboli P; Amin MB; Xu HJ; Linden MD
Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
[TBL] [Abstract][Full Text] [Related]
3. p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy.
Cheng L; Sebo TJ; Cheville JC; Pisansky TM; Slezak J; Bergstralh EJ; Pacelli A; Neumann RM; Zincke H; Bostwick DG
Cancer; 1999 Mar; 85(6):1293-9. PubMed ID: 10189134
[TBL] [Abstract][Full Text] [Related]
4. p53 Alteration and chromosomal instability in prostatic high-grade intraepithelial neoplasia and concurrent carcinoma: analysis by immunohistochemistry, interphase in situ hybridization, and sequencing of laser-captured microdissected specimens.
Al-Maghrabi J; Vorobyova L; Chapman W; Jewett M; Zielenska M; Squire JA
Mod Pathol; 2001 Dec; 14(12):1252-62. PubMed ID: 11743048
[TBL] [Abstract][Full Text] [Related]
5. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens.
Qian J; Bostwick DG
Pathol Res Pract; 1995 Sep; 191(9):860-7. PubMed ID: 8606866
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
Sasor A; Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2000; 51(1):31-6. PubMed ID: 10833901
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
[TBL] [Abstract][Full Text] [Related]
8. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
Helpap B; Riede C
Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
[TBL] [Abstract][Full Text] [Related]
9. Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations.
Shibata MA; Ward JM; Devor DE; Liu ML; Green JE
Cancer Res; 1996 Nov; 56(21):4894-903. PubMed ID: 8895741
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
11. Different patterns of p53 mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of microdissected specimens.
Yasunaga Y; Shin M; Fujita MQ; Nonomura N; Miki T; Okuyama A; Aozasa K
Lab Invest; 1998 Oct; 78(10):1275-9. PubMed ID: 9800953
[TBL] [Abstract][Full Text] [Related]
12. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
[TBL] [Abstract][Full Text] [Related]
13. Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia.
Bostwick DG
Cancer; 1996 Jul; 78(2):330-6. PubMed ID: 8674012
[TBL] [Abstract][Full Text] [Related]
14. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
Bostwick DG; Qian J; Maihle NJ
Prostate; 2004 Feb; 58(2):164-8. PubMed ID: 14716741
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor and VEGF expression in prostate carcinoma: a tissue microarray study.
Yao JL; Ryan CK; Francis CW; Kohli M; Taubman MB; Khorana AA
Cancer Invest; 2009 May; 27(4):430-4. PubMed ID: 19219655
[TBL] [Abstract][Full Text] [Related]
16. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
[TBL] [Abstract][Full Text] [Related]
17. Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate.
Helpap B
Pathol Res Pract; 1995 Sep; 191(9):904-7. PubMed ID: 8606872
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of PCNA, p53, HSP60, HSP10 and MUC-2 presence and expression in prostate carcinogenesis.
Cappello F; Rappa F; David S; Anzalone R; Zummo G
Anticancer Res; 2003; 23(2B):1325-31. PubMed ID: 12820390
[TBL] [Abstract][Full Text] [Related]
19. The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues.
Häggman MJ; Macoska JA; Wojno KJ; Oesterling JE
J Urol; 1997 Jul; 158(1):12-22. PubMed ID: 9186314
[TBL] [Abstract][Full Text] [Related]
20. A comparison of p21 and p27 immunoexpression in benign glands, prostatic intraepithelial neoplasia and prostate adenocarcinoma.
Doganavsargil B; Simsir A; Boyacioglu H; Cal C; Hekimgil M
BJU Int; 2006 Mar; 97(3):644-8. PubMed ID: 16469041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
